Apatinib for treating advanced intrahepatic cholangiocarcinoma after failed chemotherapy: A case report and literature review

RATIONALE: Intrahepatic cholangiocarcinoma (ICC) originates from the secondary branch of the bile duct and the intrahepatic bile duct epithelial cells, and is a rare pathological type of primary liver cancer. Recently, apatinib has been successfully used for a variety of malignancies. PATIENT CONCER...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li-Ye, Gong, Shuai, Gao, Li-Ping, Hou, Li-Xia, He, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310551/
https://www.ncbi.nlm.nih.gov/pubmed/30544406
http://dx.doi.org/10.1097/MD.0000000000013372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310551/
https://www.ncbi.nlm.nih.gov/pubmed/30544406
http://dx.doi.org/10.1097/MD.0000000000013372

Ejemplares similares